The comparison of the albumin values between the baseline and follow up showed an improvement only in 8.6% of the sample, while in 91.4%, the values remained stable; in addition, only 2.9% of subjects had hypoalbuminemia at the baseline. The gene discussed is ALB; the disease is Hypoalbuminemia.